ResMed Target Price Raised 5.1% to A$49.30/Share by Goldman Sachs>RMD.AU

Dow Jones22:44 ET

Leading Brokers Name 3 ASX Shares to Buy Today 28 April 2025

The Motley FoolApr 27 22:49 ET

What Does Macquarie Think ResMed Shares Are Worth?

The Motley FoolApr 27 22:05 ET

ResMed's Tariff Exemption Should Support Multiples -- Market Talk

WSJApr 27 21:20 ET

Morgans Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)

TipRanksApr 27 20:06 ET · Ratings

ResMed Price Target Cut 1.6% to A$48.00/Share by Macquarie

Dow JonesApr 27 20:03 ET · Ratings

ResMed Inc. Files Quarterly Report, Reinforces Market Position

TipRanksApr 27 18:27 ET

ResMed Inc: Form 10-Q for the Quarter Ended March 31, 2025

ASXApr 27 18:08 ET · Announcements

ResMed Inc's Earnings Call Highlights Growth and Innovation

TipRanksApr 25 20:25 ET

ResMed Inc. Stock Advances 10.1%, Outperforms Market

Dow JonesApr 24 16:34 ET

Research Alert: CFRA Reiterates Buy Recommendation On Shares Of Resmed Inc.

MT NewswiresApr 24 14:45 ET

S&P 500 Futures Fall In Premarket Trading; Texas Instruments, ServiceNow Lead

Dow JonesApr 24 07:30 ET

ResMed Inc To Go Ex-Dividend On May 7th, 2025 With 0.08243 AUD Dividend Per Share

Moomoo NewsApr 24 05:35 ET

Resmed Is Protected From Trump's Tariffs, Doesn't Plan to Raise Prices -- Interview

WSJApr 23 23:53 ET

ResMed Price Target Raised 1.8% to A$45.60/Share by Barrenjoey

Dow JonesApr 23 23:51 ET · Ratings

Express News | Resmed Inc : Piper Sandler Cuts Target Price to $248 From $260

ReutersApr 23 23:29 ET

ResMed Shares Jump 8% on Strong Q3 Update

The Motley FoolApr 23 20:25 ET

Market Mover | ResMed Shares Surge Over 7% After Reporting Higher Fiscal Q3 Earnings and Revenue

MT NewswiresApr 23 19:49 ET

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript Summary

moomoo AIApr 23 19:27 ET · Conference Call

ResMed Inc Announces New Dividend Distribution for CDIs

TipRanksApr 23 18:39 ET